Please wait...
GulfBase Live Support
- Flynas IPO: Saudi Arabia's Budget Airline Takes Flight on the Stock Market
- TAQA Group reports Q1 revenue of $ 3.87bn, up 3.8%
- Bahrain All Share Index closes higher
- UAE airline Etihad places major aircraft order with Boeing
- UN forecasts global economic growth to drop to 2.4% in 2025
- Dubai gold rate shoots up after Dh10 plus drop - in hours
- Abraj Energy signs deal with BP for drilling rig in Block 61
- Commercial Bank launches new CB Corporate Banking App
- QSE sees 62% of stocks in the red; index loses 19 points
- Financial markets development essential to Qatar's comprehensive financial strategy: QCB Governor
- :Muscat Securities Market
- :Not Listed
- :Micro Cap
- :Health Care
Company Overview
- :14/02/1996
- :OMR 5,000,000
- :OMR 00
Activities
National Pharmaceutical Industries Company (NPMI) is a public company, based in Muscat (Oman), and established in February 1996. NPMI is a subsidiary of Oman Investment Fund Holding Co. and is listed on the Muscat Securities Market since January 2005. The company specializes in the production of anti-allergic, anti-inflammatory, antidepressant,and anti-diabetic medications, and also gastrointestinal drugs. It is among the first pharmaceutical formulations manufacturing plant in Sultanate of Oman. It offers lipid lowering, cardio vascular, anti-bacterial, anti-allergic, non-steroidal anti-inflammatory, gastro intestinal, anti-diabetic, anti-depressant, and analgesic anti-pyretic products too. The company also operates worldwide in almost 12 countries and has a business base in the Gulf and Middle East counties for almost a decade. The company's facilities are spread over a 30,042.43 square meters plot of land, and includes a non-beta lactum plant for producing oral solids, liquids, drops, dry suspensions and sachets; a beta lactum plant, which engages in production of capsules and dry suspension; a research and development laboratory, and a quality control laboratory.
-
Chairman:Ghazi O. Al Zubeidi
-
Vice-chairman:Abdullah M. B. Al Qenaei
-
CEO:G . Sridhar
-
General Manager:
-
Managing Director:
-
Board Members:
Amal S. Bahwan
Khalifa S. Al Mohannadi
Mahmoud A. Zubaid
Omar S. Bahwan
-
Auditors:
Moore Stephens
National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a ...
Read More ...| Announced On | Period | As Of | Net Profit (SAR Mil) | Growth (%) |
|---|---|---|---|---|
| 15/10/2018 | 9-Month | 30/09/2018 | 01 | 25 |
| 12/04/2018 | 3-Month | 31/03/2018 | 00 | 16.39 |
| 14/01/2018 | 12-Month | 31/12/2017 | 02 | 21.33 |
| 12/10/2017 | 9-Month | 30/09/2017 | 01 | 7.05 |
| 12/07/2017 | 6-Month | 30/06/2017 | 01 | -9.96 |
- info@npioman.com
- www.npioman.com
- P.O. Box 120, Rusayl 124
| Market Cap US$ Mil |
Last Price Local Cry |
Price Change (%) 1 Day |
Price Change (%) 1 Year |
P/E TTM | P/B MRQ | Dividend Yield (%) | Beta | ROA (%) | ROE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| SULAIMANALHABIB | 25,184.25 | 268 | -0.75 | -2.58 | 42.44 | 0 | 0 | 0 | 0 | 0 |
| PUREHEALTH | 8,196.24 | 2.7 | -0.37 | 0 | 26.81 | 0 | 0 | 0 | 0 | 0 |
| ARMAH | 7,881.26 | 89.8 | -0.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NAHDI | 4,219.76 | 122.2 | 0.32 | -15.6 | 19 | 0 | 0 | 0 | 0 | 0 |
| MOUWASAT | 4,136.08 | 76.7 | -1.16 | -28.46 | 23.58 | 2.79 | 0 | 0.81 | 13.85 | 22.49 |
| JAMJOOMPHARMA | 3,357.9 | 180 | 0 | 18.09 | 36.06 | 0 | 0 | 0 | 0 | 0 |
| DALLAHHEALTH | 3,087.39 | 117 | -1.35 | -5.63 | 24.6 | 4.31 | 0 | 0.93 | 12.1 | 17.53 |
| FAKEEHCARE | 2,865.73 | 46.5 | 0.32 | 0 | 39.94 | 0 | 0 | 0 | 0 | 0 |
| AME | 2,141.59 | 115.8 | 0.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CARE | 1,941.09 | 166.2 | 2.33 | -16.19 | 26.54 | 7.55 | 0 | 0.85 | -0.59 | -0.89 |
| NABAALSAHA | 1,922.4 | 67.2 | -2.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TIBBIYAH | 1,700.27 | 31.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SAUDIGERMANHEALTH | 1,569.83 | 63.3 | -1.1 | -28.25 | 27.87 | 3.61 | 0 | 0.79 | 11.92 | 18.76 |
| PROMEDEX | 892.64 | 95.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SPIMACO | 863.46 | 26.9 | -0.38 | -2.21 | 80.02 | 1.23 | 0 | 0.91 | 8.47 | 15.11 |
| ALMUJTAMAMEDICAL | 784.84 | 32 | 3.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AVALONPHARMA | 688.64 | 126.8 | -1.86 | 0 | 32.12 | 0 | 0 | 0 | 0 | 0 |
| MIRAL | 621.48 | 116.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MIDAN | 524.21 | 789 | 0 | -4.78 | 14.01 | 1.38 | 0 | 0 | 12.06 | 17.87 |
| QOMEL | 508.35 | 55 | 0.91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JULPHAR | 446.52 | 1.38 | -2.82 | 0 | -71.36 | 0.69 | 5.27 | 0.2 | 4.09 | 0 |
| AYYAN | 401.76 | 14.7 | -1.87 | -8.1 | -7.15 | 1.5 | 0 | 0.81 | -2 | -2.64 |
| GMPC | 393.81 | 2.14 | 3.38 | 0 | 0 | 1.1 | 3 | -0.08 | 75.81 | 111.42 |
| ATC.KW | 364.68 | 741 | 0 | 0 | 157.88 | 2.25 | 1.82 | -0.01 | 2.93 | 12.88 |
| MCGS | 346.4 | 4.64 | 2.65 | -0.04 | 21.18 | 0.13 | 5.86 | 0.98 | 6.76 | 7.99 |
| EQUIPMENTHOUSE | 324.2 | 39.9 | -1.61 | 5.1 | 25.3 | 0 | 0 | 0 | 0 | 0 |
| LANA | 287.82 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TMC | 229.4 | 22 | 2.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RPM | 223.75 | 4.21 | 2.43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BURJEEL | 209.69 | 1.46 | -1.36 | 0 | 1.65 | 0 | 0 | 0 | 0 | 0 |
| CMCER | 143.64 | 6.93 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALMODAWAT | 113.8 | 18.12 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FUTURECARE | 50.77 | 3.73 | -2.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QGMD | 43.09 | 1.37 | 0 | 16.69 | -2.31 | 0.23 | 0 | 0.76 | -6.18 | 0 |
| SMILECARE | 30.65 | 5.72 | -0.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BALSMMEDICAL | 25.65 | 77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALRAZI | 17.09 | 42.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JANA | 14.49 | 16.6 | -1.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Information Co.
P.O. Box 69410, Jeddah 11547, Saudi Arabia